Over 1.8 million nonprofits and charities for donors, volunteers and funders

2016 Top-Rated Nonprofit

Multidisciplinary Association For Psychedelic Studies

Claim This Nonprofit

More Info

Add to Favorites

Share this Nonprofit

Donate

Volunteering Oportunities

Nonprofit Overview

Causes: Government & Public Administration, Health, Medical Research, Mental Health, Mental Health Treatment

Mission: Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. MAPS furthers its mission by: -Developing psychedelics and marijuana into prescription medicines -Training therapists and working to establish a network of treatment centers -Supporting scientific research into spirituality, creativity, and neuroscience -Educating the public honestly about the risks and benefits of psychedelics and marijuana MAPS envisions a world where psychedelics and marijuana are safely and legally available for beneficial uses, and where research is governed by rigorous scientific evaluation of their risks and benefits.

Results: MAPS has completed two Phase 2 FDA studies using MDMA-assisted psychotherapy to treat PTSD, and is in the process of four other similar studies. MAPS also has a study looking at LSD-assisted psychotherapy for treating end-of-life anxiety, an outcome study of the benefits of ibogaine for opiate dependence, and a protocol to investigate medical marijuana to relieve symptoms of PTSD.

Target demographics: Any person whose life may be aided by the transformative nature of psychedelic psychotherapy

Geographic areas served: Worldwide

Programs: Maps' primary focus is research into mdma-assisted psychotherapy ($1,094,575), especially phase 2 research into mdma-assisted psychotherapy in subjects with chronic, treatment-resistant ptsd. In this fiscal year, maps treated the 18th subject in our charleston, south carolina mdma/ptsd study in 24 veterans, firefighters and police officers. An 8th subject was treated in our study in boulder, colorado for people suffering from ptsd from any source, a fourth subject was treated in our mdma/ptsd study in beer yaakov, israel, and an irb approved the amendments for our mdma/ptsd study in vancouver, canada. A 7th therapist participated in our mdma-assisted psychotherapy therapist training study. In addition to our core clinical research, this fiscal year we began planning a series of studies in collaboration with researchers who work with the u. S. Department of veterans affairs' national center for ptsd. We'll be exploring the use of mdma along with more traditional psychotherapeutic methods for treating ptsd including cognitive-behavioral conjoint therapy, cognitive processing therapy, and prolonged exposure therapy. We also began our study looking at the safety and efficacy of using mdma-assisted therapy for anxiety in adults on the autism spectrum and began preparations for a study of mdma-assisted psychotherapy for end-of-life anxiety. These studies will grow significantly in the coming year. Mdma-study related program expenses include costs of video data storage and streaming systems development, budgeting, contracting, and meetings; the costs of developing the treatment manual; training therapists; blinded therapist adherence training; and costs of reviewing and documenting all published mdma literature. There are also mdma-study related supervision of therapists, presentation of our data at professional conferences, and costs to manage the mdma purchased early in our work and to secure the drug for phase 3 trials expected to begin in 2016. Clinical research general costs cover the development of the infrastructure needed for our mdma clinical trials, including work with communications and fundraising departments, staff professional development and conferences, and video streaming and statistical software. Most of the clinical research expenses are personnel, including personnel at each study site: principal investigators, co-investigators, independent raters, overnight physicians, attendant, and study coordinators, as well as maps' internal staff: the clinical director, research associates, information specials, data coordinators and statistical consultants. Ibogaine research expenses were dedicated to completing our studies in mexico ($3,816), and new zealand ($6,329). Lsd research expenses ($12,185) were primarily used for the march 2014 publication of our lsd end-of-life anxiety article in the journal of nervous and mental disease. Marijuana research ($14,905) covered the costs of developing the protocol for a pilot study in which marijuana will be tested to manage symptoms in 76 veterans with chronic, treatment-resistant ptsd, and our efforts to end the public health service (phs) review and the national institute of drug abuse (nida) monopoly of the sale of marijuana for clinical research.

education expenses include harm reduction, events, publications and communications programs. Our zendo project provides a supportive space for people undergoing difficult psychedelic experiences in order to help turn those experiences into opportunities for learning and personal growth, and to reduce the number of drug-related psychiatric hospitalizations and arrests. Services were provided at five major events in fiscal year 2014: burning man (black rock city, nv), envision (costa rica), afrikaburn (south africa), bicycle day (san francisco, ca), and lightning in a bottle (bradley, ca). In order to share recent findings and to inspire existing and new support, maps produced events on psychedelic and marijuana research in colorado, vancouver and santa cruz; and attended more than 17 events that others produced, providing speakers, exhibits, sales of books and maps bulletins, and free distribution of clinical protocols and articles from peer-reviewed journals. Communications included publishing three maps bulletins, and 12 email newsletters, maintaining maps. Org, mdmaptsd. Org, mapscanada. Org, psychedelicscience. Org, and launching mdma-autism. Org. Maps produced "manifesting minds," with north atlantic books, reprinted albert hofmann's "lsd: my problem child," and began work with stanislav grof on his new book, "the visionary world of h. R. Giger. " in spring 2014, maps offered its first webinar, "psychedelic science," in collaboration with evolver learning labs. Maps saw significant growth in coverage of its work in social, online, and traditional media. Maps. Org had 511,449 unique visits and 1,809,246 page views. Facebook likes more than doubled to 89,282. Twitter followers increased 140%, to 17,099. Youtube subscriptions increased 256% to 5,313. Maps received 344 unique media mentions from online and print publications with significant reach. Media outlets include the los angeles times, the new york times, the san francisco chronicle, reason, scientific american, cnn, usa today, msnbc, time, associated press, fox news, forbes, nbc news, playboy, santa cruz sentinel, tricycle, business insider, npr, vice, and southern california public radio (kpcc).

this year, maps operationalized its long-running fiscal sponsorship program, clarifying and updating contracts, process, and structure. This program supports projects that are in alignment with maps mission and vision by offering donors a way to give to a 501(c) 3 nonprofit organization. Maps monitors the project budget, takes a small fee, and sends the donor a receipt for their contribution.

Community Stories

130 Stories from Volunteers, Donors & Supporters

4

Professional with expertise in this field

Rating: 5

Despite nearly universal examples of positive uses of psychedelic substances in the history of cultures worldwide, the political climate has made the exploration and understanding of these uses impossible for far too long. MAPS has done a fantastic job of bringing common sense and scientific rigor to the pursuit of this research, and persevered through very difficult cultural and political challenges. Thank you MAPS for the work you've done, and for the many people who will be able to benefit from your research!

Review from Guidestar

5

Professional with expertise in this field

Rating: 4

I became addicted to narcotic pain medication that was prescribed for me to deal with migraine headaches. Eventually I couldn't get enough prescription medication and had to go to the street and start buying heroin. I then became a heroin addict. Altogether I was strung out for 22 years, during which time I attempted 15 different treatment programs. All detoxified me, but the multidimensional character of addiction required more than that. Finally I was dying of morphine toxicity when I discovered an experimental ibogaine trial being conducted and by good fortune was able to participate. One dose relieved all my symptoms, without withdrawal, and left me teachable and open to lifestyle changes. I did the recovery work necessary; now I have 13 years clean and am a doctoral student in psychology. I attended the MAPS conference in April and was greatly impressed by the large number of serious professionals in attendence, all of whom were excited by the way the field is finally beginning to come out from under the odium inflicted upon it by the hysterical press and misinformed actions of the relevant government agencies back in the 60s. MAPS emphasizes the value of psychedelic substances as therapeutic adjuncts and as research vectors in the study of neurology and human consciousness, which topics already have a substantial body of research validating this view. I find the MAPS mission statement too conservative in its estimation of the numbers of people who could be served by such research since the number of traumatized veterans of Viet Nam, Iraq and Afganistan is much larger than "thousands," while there are also a huge number of people in the world, even in this country, who have been traumatized by sources other than war. The work of MAPS is of vital interest to the welfare of our nation and to addressing the plight of millions of suffering people.

5

Professional with expertise in this field

Rating: 5

Psychedelics have assisted me in treating alcoholism & undoing the anger associated with a close family member during young age. The organization has done amazing to shed light on such a powerful tool of healing to get this more mainstream. MAPS serves as a powerful tool to promote psychedelics as more than a "trippy experience". Very proud to be a MAPS member & contributor.

4

Professional with expertise in this field

Rating: 5

MAPS, along with the Vaults of Erowid, is a vital resource for the very real healing offered by psychedelics and shamanism. I was a life long sufferer of severe asthma and whole body eczema - my life is veritably defined by these disorders - and I have been healed with the help of ayahuasca and LSD. This may sound incredible to anyone bombarded by commercials for inhalers and hydrocortisone, but it is a fact that many of us have been healed by the careful and informed use of sacred plants. Thanks to MAPS and Erowid, information and research on psychedelics, this news will start to sound commonplace, and many more will be healed.

Review from Guidestar

4

Professional with expertise in this field

Rating: 5

MAPS is an organization which is leading the way in what I believe will be the next great scientific breakthrough of our age. The introduction of psychedelics into clinical therapy is positively groundbreaking and has the potential to change the face of psychology forever.

4

Professional with expertise in this field

Rating: 5

What can I say about Rick Doblin and MAPS? He has taken part in truly one of the most challenging marathons, by offering insight, knowledge and scientific attestation while wading through Federal red tape for the betterment of our society. Thank you!!

Review from Guidestar

4

Professional with expertise in this field

Rating: 5

this organization is working to break stereotypes and gain awareness for mental heath research. MAPS is a organization that has work not just to fund forward thinking research, but to aid in the diffusion of knowledge between scientific specialization's. MAPS has shown over the years that they have already effected the modern mental health science thru there record and staying power.

Review from Guidestar

4

Professional with expertise in this field

Rating: 5

Outstanding organization on the cutting edge of a revolution in psychopharmacology. Funds and organizes scientifically based therapeutic interventions. The lead organization in the field of psychedelic research.

Review from Guidestar

4

Professional with expertise in this field

Rating: 5

MAPS brings something back we had lost for decades: serious inquiry into the effects and health benefits of psychotropic substances such as psylocybin, LSD, MDMA, tools for exploration into the nature of man and its soul.

Review from Guidestar

4

Professional with expertise in this field

Rating: 5

I am so grateful to what MAPS brings to the world. Their work in educating people accurately about psychedelics and marijuana and their appropriate therapeutic potential, as well as their funding of research in this field, is invaluable. There are so many illnesses that are untreatable by current medical treatments and yet we have available to us substances that *are* effective and safe for so many people. As a psychiatrist for 10 years who now uses alternative healing techniques, I am very familiar with severe mental illnesses in particular that do not respond to conventional treatment but can respond to psychedelics when appropriately, therapeutically used. The current research going on around the world (much funded by MAPS) attests to this, as do past studies.

4

Professional with expertise in this field

Rating: 5

I personally can attest to the value of psychedelic research to help terminal ill patients and people with mental health challenges. As a psychologist, I contest the use of psychotropic medications for the majority of individuals; only in cases of severe mental illness is it valuable. Otherwise, people need a way to get to the core of their own values and understanding about their position in life. We need medicines that can be applied for short term use for long term consequences of improvement and sound mental health. I have supported MAPS Research since the beginning of their quest and I appeal to you to support them too!

Review from Guidestar

4

Professional with expertise in this field

Rating: 5

MAPS is a vehicle that brings forward extraordinary wealth of new research and information. Not only does this new yet also ancient knowledge aid us in understanding more about the human mind and condition, it also provides us with tools to help individuals with mental health disorders. This is an area of medicine where treatment outcomes often time leave much to be desired. We would be simply foolish to ignore or overlook what psychedelic research has to offer.

Review from Guidestar

4

Professional with expertise in this field

Rating: 5

MAPS is a truly unique organization in the world providing scientific and clinical data in an area of great controversy and doing so honestly and critically. MAPS support for basic science and human clinical research with a variety of psychoactive substances has been invaluable in opening the possibility for humans to benefit from valuable therapies that should be legal and available. MAPS has played the leading role in funding and supporting invaluable investigation.

4

Professional with expertise in this field

Rating: 5

MAPS is a unique and important organization - they are at the cutting edge of the coming expansion of thinking both about drugs and about the larger agenda of healing - and the vital role that individuals now experimenting on themselves can play in establishing a meaningful base of evidence for new therapeutic uses of many drugs. As a researcher I have found their work invaluable,

Review from Guidestar

5

Professional with expertise in this field

Rating: 5

MAPS has been instrumental in investigating and disseminating news regarding medical marijuana and other important substances. Thanks to MAPS for doing incredible work in these fields.

3

Professional with expertise in this field

Rating: 5

I've been a MAPS member since 1996 & contribute at intervals to the discussions on e-list, communicating specialized knowledge that I have to non-specialists on the list. I depend on MAPS' newsletter & magazine for news about the progress of research. I also attended the April conference in San Jose, which was a wonderful source of learning and opportunity for networking.

Review from Guidestar

6

Professional with expertise in this field

Rating: 5

Psychedelic drugs have been used for millenia by certain indigenous cultures but have yet to find a legitimate place in Western medicine and psychiatry. MAPS is dedicated to supporting research on potential medical and psychiatric applications of these powerful agents. Scientific efforts to understand the most mysterious phenomenon of nature, consciousness, are also likely to benefit from psychedelic research.

6

Professional with expertise in this field

Rating: 5

By investigating the ever-expanding field of psychedelic studies, MAPS puts people better in touch not only with the scientific world of mind-altering chemicals, but also in touch with their own psychological centers and with other valuable minds in the field. Their work is essential to the increased understanding and acceptance that psychedelic research requires to metamorphose into one of the most important fields of the coming century.

Review from Guidestar

6

Professional with expertise in this field

Rating: 5

MAPS raises and provides funding for solid, fact-based medical and scientific research into the effects and uses of substances like LSD, psilocybin, and MDMA.

4

Professional with expertise in this field

Rating: 5

MAPS is the most relevant, clever and generous world-class NP organization ever created to promote dispassionate, rational, scientific, and ultimately beneficial approach and uses of psychedelics in First World societies.

Review from Guidestar